A

Active Director Director DIN 10332067
DIN 10332067 First appointment Nov 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Athira

Data last updated:

Athira is a Director at Nimitz Bio Tech Private Limited (since 2023). The company operates in Trading. Nimitz Bio Tech Private Limited reported revenue of ₹17.5 Lakh (FY 2023).

DIN 10332067
Primary Designation Director
Industry Trading
First Appointment 16 Nov 2023
Oldest Company Age 6 yrs
Largest company Nimitz Bio Tech Private Limited · ₹17.5 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nimitz Bio Tech Private Limited U51909KL2020PTC063043
Director16 Nov 20232020₹17.5 Lakh (FY 2023)Active

Directorship timeline

Open interactive timeline →
Nimitz Bio Tech Private Limited
Premium access

Shareholding and investment profile for Athira

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Athira

Athira currently holds 1 directorship: Nimitz Bio Tech Private Limited (Director, since 16 Nov 2023, revenue ₹17.5 Lakh (FY 2023)).

Athira was first appointed on 16 Nov 2023 as Director at Nimitz Bio Tech Private Limited.

The current boards of Athira's companies include Deepa Raj Rajendran (Nimitz Bio Tech Private Limited), Parambikkudy Sathyapalan Manu (Nimitz Bio Tech Private Limited), Thoopeliparambu Suku Sumesh (Nimitz Bio Tech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available